prof quentin pankhurst
- Prof Quentin Pankhurst
- Ex: 51124
- Professor of Physics Director Institute of Biomedical Engineering
- Head of Department
- Institute of Biomedical Engineering
- Faculty of Engineering Science
Research SummaryAs a research scientist, Pankhurst runs research programmes in bio- and nanomagnetism aimed at making practical advances in the use of magnetic nanoparticles in healthcare. These include a medical tool for breast cancer staging; a molecular imaging microscope for living cells; and the development of multi-functional nanoparticles for therapy and diagnostics.
- Development of Rapid Prototypes for Muscle Augmentation Using Magnetic Augmentation
- Effect of Tumour Biology on Therapeutic Response
- Self propagating high temperature synthesis
- Understanding the role of stem cells in cancer development
Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial.
Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.
Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model.
Development of Hyperthermia Treatments for Malignant Melanoma using Superparamagnetic Iron Oxide Nanoparticles in a Novel Transgenic In Vivo Model
1986PhDDoctor of PhilosophyUniversity of Liverpool
1982BSc HonsBachelor of Science (Honours)University of Canterbury
In May 2008, UCL and the Royal Institution of Great Britain entered into a five-year programme of Joint Research Activities in healthcare biomagnetics, led by Quentin Pankhurst, who was both appointed as Director of the Davy-Faraday Research Laboratory at the RI, and retained as a part-time Professor of Physics at UCL. At the RI, Pankhurst runs research programmes in bio- and nanomagnetism aimed at making practical advances in the use of magnetic nanoparticles in healthcare. These include medical imaging devices, targeted regenerative medicine, molecular imaging microscopy for living cells, and the development of multi-functional nanoparticles for therapy and diagnostics. Pankhurst is also a founder and the current CTO of Endomagnetics Ltd, a spin-out company which in 2010 gained a CE mark for, and started selling, the SentiMag - an intra-operative medical device for breast cancer surgery.
- prof barbara pedley
- prof daniel hochhauser
- prof hans stauss
- dr gaetano burriesci
- dr richard day
- prof ivan gout
- dr sean nair
- prof mervyn singer
- dr anton emmanuel
- prof ivan parkin
- prof paul beard
- prof samuel janes
- prof mark lythgoe
- prof chris boshoff
- dr erik arstad